Peter Speelman

11.7k citations
139 papers · 8.8k · 1 hit paper · h-index 49

Impact in

  • Infectious Diseases top 0.2%
    • Clostridium difficile and Clostridium perfringens research
    • Tuberculosis Research and Epidemiology
    • Viral gastroenteritis research and epidemiology
  • Gastroenterology top 0.5%
    • Gastrointestinal motility and disorders

Papers in

  • Epidemiology 56
    • Pneumonia and Respiratory Infections 21
    • Mycobacterium research and diagnosis 9
  • Infectious Diseases 49
    • Tuberculosis Research and Epidemiology 14
    • Clostridium difficile and Clostridium perfringens research 12
    • Viral gastroenteritis research and epidemiology 12
Co-authors
Ed J. Kuijper (14 shared papers)Tom van der Poll (39 shared papers)Jan M. Prins (29 shared papers)Els van Nood (4 shared papers)Josbert J. Keller (4 shared papers)Sander J. H. van Deventer (32 shared papers)Max Nieuwdorp (3 shared papers)J. F. W. M. Bartelsman (3 shared papers)
Journals
The Journal of Infectious Diseases (18 papers)Infection and Immunity (8 papers)Clinical Infectious Diseases (7 papers)Antimicrobial Agents and Chemotherapy (7 papers)European Journal of Clinical Microbiology & Infectious Diseases (6 papers)
Partner nations
NetherlandsUnited StatesVietnam

In The Last Decade

Peter Speelman

136 papers receiving 8.5k citations

Peter Speelman's Hit Papers

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile 2013 · 2.7k citations
2.7k0+4+8Years since publication50010001.5k2.0k2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2013 New England Journal of Medicine

Peers

Peter Speelman
Comparison fields: 5 of 151
  • Infectious Diseases 3.7k
  • Gastroenterology 852
  • Applied Microbiology and Biotechnology 290
  • Endocrinology 633
  • Epidemiology 3.4k
Replace Jan Verhaegen with:
Jan Verhaegen Belgium
George A. Sarosi United States
Evangelos J. Giamarellos‐Bourboulis Greece
Peter H. Gilligan United States
Carl Erik Nord Sweden
Carles Úbeda Spain
Jaap T. van Dissel Netherlands
S. L. Gorbach United States
Julie Parsonnet United States
Stuart H. Cohen United States
Peter Speelman relative to Jan Verhaegen Belgium Jan Verhaegen's profile →
Citations per field
00.5×1.5×2×2.4×
Jan Verhaegen · 1×
Citations per year

Countries citing papers authored by Peter Speelman

Since Specialization
Citations

This map shows the geographic impact of Peter Speelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Speelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Speelman more than expected).

Fields of papers citing papers by Peter Speelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Speelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Speelman. The network helps show where Peter Speelman may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Speelman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Speelman Line = papers co-authored together Peter Speelman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
New England Journal of Medicine ·Els van Nood, Anne Vrieze, Max Nieuwdorp, Susana Fuentes, Erwin G. Zoetendal, Willem M. de Vos, Caroline E. Visser, Ed J. Kuijper, J. F. W. M. Bartelsman, Jan G.P. Tijssen, Peter Speelman, Marcel G. W. Dijkgraaf, Josbert J. Keller
Hit paper breakdown →		20132685
2
Once versus thrice daily gentamicin in patients with serious infections
The Lancet ·Jan M. Prins, Harry R. Büller, Peter Speelman, Ed J. Kuijper, R. A. Tange
1993265
3
Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study
BMJ ·Rachida el Moussaoui, Corianne A.J.M. de Borgie, Peterhans van den Broek, W N M Hustinx, Paul Bresser, Guido E.L. van den Berk, Jan‐Werner Poley, Bob van den Berg, Frans H. Krouwels, Marc J. M. Bonten, Carla Weenink, Patrick M. Bossuyt, Peter Speelman, Brent C. Opmeer, Jan M. Prins
2006232
4
Interleukin‐1 Signaling Is Essential for Host Defense during Murine Pulmonary Tuberculosis
The Journal of Infectious Diseases ·Nicole P. Juffermans, Sandrine Florquin, Luisa Camoglio, Annelies Verbon, A H Kolk, Peter Speelman, Sander J. H. van Deventer, Tom van der Poll
2000227
5
A Large Outbreak of Legionnaires’ Disease at a Flower Show, the Netherlands, 1999
Emerging infectious diseases ·Jeroen W. Den Boer, Ed P. F. Yzerman, Joop Schellekens, Kamilla D. Lettinga, Hendriek C. Boshuizen, Jim van Steenbergen, A Bosman, Susan van den Hof, Hans A. Van Vliet, Marcel F. Peeters, R J van Ketel, Peter Speelman, Jacob L. Kool, Marina A.E. Conyn Van Spaendonck
2002210
6
Role ofToll-Like Receptor 4 in Gram-Positive and Gram-Negative Pneumonia inMice
Infection and Immunity ·Judith Branger, Sylvia Knapp, Sebastiaan Weijer, Jaklien C. Leemans, Jennie M. Pater, Peter Speelman, Sandrine Florquin, Tom van der Poll
2004196
7
Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment
Clinical & Experimental Immunology ·Annelies Verbon, Nicole P. Juffermans, Sander J. H. van Deventer, Peter Speelman, Henk van Deutekom, Tom van der Poll
1999188
8
Urokinase Receptor Is Necessary for Adequate Host Defense Against Pneumococcal Pneumonia
The Journal of Immunology ·Anita W. Rijneveld, Marcel Levi, Sandrine Florquin, Peter Speelman, Peter Carmeliet, Tom van der Poll
2002151
9
Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital
Journal of Antimicrobial Chemotherapy ·Fatma Sevinç, Jan M. Prins, Richard P. Koopmans, Pim N.J. Langendijk, Patrick M. Bossuyt, J. Dankert, Peter Speelman
1999131
10
Elevated Plasma Concentrations of Interferon (IFN)–γ and the IFN‐γ–Inducing Cytokines Interleukin (IL)–18, IL‐12, and IL‐15 in Severe Melioidosis
The Journal of Infectious Diseases ·Fanny N. Lauw, Andrew J. H. Simpson, Jan M. Prins, Michael D. Smith, Masashi Kurimoto, S. J. H. Van Deventer, Peter Speelman, Wipada Chaowagul, Nicholas J. White, Tom van der Poll
1999128
11
Assessment of splenic function
European Journal of Clinical Microbiology & Infectious Diseases ·Alexander P. de Porto, Adriana J. J. Lammers, Roel J. Bennink, Ineke J. M. ten Berge, Peter Speelman, J. B. L. Hoekstra
2010127
12
Clinical relevance of antibiotic-induced endotoxin release
Antimicrobial Agents and Chemotherapy ·Jan M. Prins, S J van Deventer, Ed J. Kuijper, Peter Speelman
1994121
13
Detection of enterotoxigenic Escherichia coli in stool samples by using nonradioactively labeled oligonucleotide DNA probes and PCR
Journal of Clinical Microbiology ·Constance Schultsz, G J Pool, Ruud van Ketel, Bob de Wever, Peter Speelman, J. Dankert
1994110
14
TNF-α Compensates for the Impaired Host Defense of IL-1 Type I Receptor-Deficient Mice During Pneumococcal Pneumonia
The Journal of Immunology ·Anita W. Rijneveld, Sandrine Florquin, Judith Branger, Peter Speelman, Sander J. H. van Deventer, Tom van der Poll
2001103
15
Antibiotic-Induced Endotoxin Release in Patients with Gram-Negative Urosepsis: A Double-Blind Study Comparing Imipenem and Ceftazidime
The Journal of Infectious Diseases ·Jan M. Prins, Michiel A. van Agtmael, Ed J. Kuijper, S. J. H. Van Deventer, Peter Speelman
199597
16
IL-18 Improves the Early Antimicrobial Host Response to Pneumococcal Pneumonia
The Journal of Immunology ·Fanny N. Lauw, Judith Branger, Sandrine Florquin, Peter Speelman, Sander J. H. van Deventer, Shizuo Akira, Tom van der Poll
200287
17
Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum
Infection and Immunity ·Jan M. Prins, Ed J. Kuijper, Marcel L.C.M. Mevissen, Peter Speelman, S J van Deventer
199586
18
CpG Oligodeoxynucleotides Enhance Host Defense during Murine Tuberculosis
Infection and Immunity ·Nicole P. Juffermans, Jaklien C. Leemans, Sandrine Florquin, Annelies Verbon, A H Kolk, Peter Speelman, Sander J. H. van Deventer, Tom van der Poll
200283
19
Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide
Blood ·Anita W. Rijneveld, Sebastiaan Weijer, Sandrine Florquin, Charles T. Esmon, Joost C.M. Meijers, Peter Speelman, Pieter H. Reitsma, Hugo Ten Cate, Tom van der Poll
200379
20
Struggling with recurrent Clostridium difficile infections: is donor faeces the solution?
Eurosurveillance ·Els van Nood, Peter Speelman, Ed J. Kuijper, Josbert J. Keller
200978

About Peter Speelman

Peter Speelman is a scholar working on Epidemiology, Infectious Diseases, Immunology, Surgery and Pharmacology, having authored 139 papers that have together received 8.8k indexed citations. Recurring topics across this work include Immune Response and Inflammation (28 papers), Pneumonia and Respiratory Infections (21 papers), Tuberculosis Research and Epidemiology (14 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Clostridium difficile and Clostridium perfringens research (12 papers), Viral gastroenteritis research and epidemiology (12 papers), Mycobacterium research and diagnosis (9 papers) and Vector-borne infectious diseases (7 papers). The work is most often cited by research in Infectious Diseases (3.7k citations), Gastroenterology (852 citations), Applied Microbiology and Biotechnology (290 citations), Endocrinology (633 citations) and Epidemiology (3.4k citations). Peter Speelman has collaborated with scholars based in Netherlands, United States and Vietnam. Frequent co-authors include Ed J. Kuijper, Tom van der Poll, Jan M. Prins, Els van Nood, Josbert J. Keller, Sander J. H. van Deventer, Max Nieuwdorp, J. F. W. M. Bartelsman, Caroline E. Visser and Susana Fuentes. Their work appears in journals such as The Journal of Infectious Diseases, Infection and Immunity, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and European Journal of Clinical Microbiology & Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan VerhaegenBreakdown of academic impact, for papers by George A. SarosiBreakdown of academic impact, for papers by Evangelos J. Giamarellos‐BourboulisBreakdown of academic impact, for papers by Peter H. GilliganBreakdown of academic impact, for papers by Carl Erik NordBreakdown of academic impact, for papers by Carles ÚbedaBreakdown of academic impact, for papers by Jaap T. van DisselBreakdown of academic impact, for papers by S. L. GorbachBreakdown of academic impact, for papers by Julie ParsonnetBreakdown of academic impact, for papers by Stuart H. Cohen